SPG21 Gene SPG21 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for SPG21 Gene SPG21 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SPG21 Gene SPG21
Test Details
The SPG21 gene is associated with a rare genetic disorder called hereditary spastic paraplegia type 21 (SPG21). This disorder is characterized by progressive muscle stiffness and weakness in the lower limbs, leading to difficulty walking.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of SPG21, NGS genetic testing can be used to identify mutations or variations in the SPG21 gene that may be responsible for causing hereditary spastic paraplegia type 21.
By identifying these genetic changes, NGS genetic testing can help confirm a diagnosis of SPG21 and provide important information for genetic counseling and management of the condition. It can also be used for carrier testing in individuals with a family history of SPG21, as well as for prenatal or preimplantation genetic diagnosis in at-risk pregnancies.
Overall, SPG21 NGS genetic testing plays a crucial role in the diagnosis and management of hereditary spastic paraplegia type 21, allowing for personalized treatment and family planning options.
Test Name | SPG21 Gene SPG21 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SPG21 Gene SPG21 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SPG21 Gene SPG21 |
Test Details |
The SPG21 gene is associated with a rare genetic disorder called hereditary spastic paraplegia type 21 (SPG21). This disorder is characterized by progressive muscle stiffness and weakness in the lower limbs, leading to difficulty walking. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of SPG21, NGS genetic testing can be used to identify mutations or variations in the SPG21 gene that may be responsible for causing hereditary spastic paraplegia type 21. By identifying these genetic changes, NGS genetic testing can help confirm a diagnosis of SPG21 and provide important information for genetic counseling and management of the condition. It can also be used for carrier testing in individuals with a family history of SPG21, as well as for prenatal or preimplantation genetic diagnosis in at-risk pregnancies. Overall, SPG21 NGS genetic testing plays a crucial role in the diagnosis and management of hereditary spastic paraplegia type 21, allowing for personalized treatment and family planning options. |